...
首页> 外文期刊>International Journal of Nanomedicine >cRGDfK-Grafted Small-Size Quercetin Micelles For Enhancing Therapy Efficacy Of Active Ingredient From The Chinese Medicinal Herb
【24h】

cRGDfK-Grafted Small-Size Quercetin Micelles For Enhancing Therapy Efficacy Of Active Ingredient From The Chinese Medicinal Herb

机译:CRGDFK接枝的小型槲皮素胶束,用于增强中药草药的活性成分治疗疗效

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: As an active ingredient of Chinese herbal medicine, quercetin (QU) can significantly induce apoptosis of tumor cells and give play to other effect such as decreasing both fibroblast population and collagen in cancer cell nest. However, the antitumor efficacy of quercetin was mostly evaluated at cellular level and rarely developed in vivo by intravenous injection, which may be ascribed to its inferior physicochemical properties including water insolubility, short plasma half-time, and insufficient enrichment in the tumor tissues. Methods: The DSPE-PEG was used to construct quercetin-loaded micelles, and the integrin ligand cRGDfK was grafted to modify the nanocarrier for enhancing its cancer-specific homing. The MALDI-TOF-MS, DLS, TEM, and UV were orderly operated to characterize guidance molecules and micelles by morphology, size distribution, Zeta potential, and drug encapsulation efficiency. In addition, the surface plasmon resonance study and real-time confocal analysis were employed to demonstrate αsubv/subβsub3/sub integrin-overexpressing B16 cells-specific binding and uptake. After further pharmacodynamics studies in vitro and in vivo, we also evaluate systemic toxicity about cRGDfK-PM-QU. Results: The cRGDfK was successfully stitched with DSPE-PEG and modified on the surface of micelles. The ligand modification enhanced the negative charges of the micelles, but it did not induce significant changes in particle size. The quercetin micelles were about 15 nm in size and negatively charged, and had spherical morphology and high drug encapsulation efficiency. In vitro, the cRGDfK-modified micelles (cRGDfK-PM) showed αsubv/subβsub3/sub integrin-overexpressing B16 cells-specific binding and uptake, and cRGDfK-PM-QU (QU loaded in cRGDfK-PM) induced more significant cell apoptosis and cytotoxic effects against B16 tumor cells than counterpart micelles (PM-QU). In vivo, the cRDGfK modification enhanced enrichment in B16 tumor tissue, improved the therapeutic efficacy of the quercetin-loaded micelles against B16 tumor, and exhibited lower systemic and pulmonary toxicity compared with counterpart micelles in the mouse mode. Conclusion: Quercetin as a natural product has triggered increasing interest in the antitumor field. In this study, cRGDfK-modified DSPE-PEG micelles significantly optimized quercetin therapeutic efficacy and pulmonary toxicity as well as lowered systemic toxicity.
机译:背景:作为中草药的活性成分,槲皮素(Qu)可以显着诱导肿瘤细胞的凋亡,并发挥其他疗效,例如降低癌细胞巢中的成纤维细胞群和胶原蛋白。然而,槲皮素的抗肿瘤功效大多数在细胞水平下评估,并且通过静脉注射很少在体内开发,这可以归因于其劣质物理化学性质,包括水不溶性,短的血浆半时间,肿瘤组织中的富集不充分的富集。方法:DSPE-PEG用于构建槲皮素加载的胶束,接枝整联蛋白配体CRGDFK以改变纳米载体,以增强其癌症特异性归巢。有序地操作Maldi-Tof-MS,DLS,TEM和UV,以通过形态,尺寸分布,Zeta电位和药物包封效率表征引导分子和胶束。此外,使用表面等离子体共振研究和实时共焦分析来证明α<亚> v β 3 整合蛋白过表达B16细胞特异性结合和摄取。经过进一步的药效学研究体外和体内,我们还评估了关于CRGDFK-PM-Qu的系统性毒性。结果:CRGDFK用DSPE-PEG成功缝合,并在胶束表面进行改性。配体改性增强了胶束的负电荷,但它没有诱导粒度的显着变化。槲皮素胶束的尺寸约为15nm,带负电,具有球形形态和高药物包封效率。体外,CRGDFK改性胶束(CRGDFK-PM)显示α<亚> v β 3 整合蛋白过度表达B16细胞特异性结合和摄取,以及CRGDFK-PM-QU( CRGDFK-PM中加载的QU)诱导比对应胶束(PM-QU)对B16肿瘤细胞的更显着的细胞凋亡和细胞毒性作用。在体内,CRDGFK改性增强了B16肿瘤组织的富集,改善了槲皮素加载的胶束对B16肿瘤的治疗效果,与小鼠模式中的对应胶束相比表现出较低的全身和肺毒性。结论:槲皮素作为天然产物引发了抗肿瘤场的兴趣。在本研究中,CRGDFK改性的DSPE-PEG胶束显着优化了槲皮素治疗疗效和肺毒性,并降低了系统性毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号